Donate
Call the Lung HelpLine
Ask a Question
The following text field filters the results that follow as you type. Use Tab to access the results.
  1. Home
  2. Research & Reports
  3. About Our Research
  4. Previously Funded Researchers
  5. Peter Kaiser, Ph.D.
Peter Kaiser, Ph.D.

Peter Kaiser, Ph.D.

University of California, Irvine

Research Project:
Drugs to Reactivate Tumor-Killing Ability of p53

Research Topics:

  • gene expression transcription
  • gene therapy

Research Disease:

  • lung cancer

One of the most commonly mutated genes in cancer and one of the most difficult proteins to target therapeutically is p53. The malfunction of p53 is crucial for the origin and spread of lung cancer. We aim develop new cancer drugs targeting p53 to help patients suffering from this terrible disease. Drugs able to reactivate the tumor-killing ability of p53 will be a significant new treatment option for thousands of lung cancer patients and will also improve treatment options for patients fighting other types of cancers.

Page last updated: April 18, 2024

Asthma Educator Institute
, | Jul 11, 2015
See All Events